IPILIMUMAB N01

Clinical trials for IPILIMUMAB N01 explained in plain language.

Never miss a new study

Get alerted when new IPILIMUMAB N01 trials appear

Sign up with your email to follow new studies for IPILIMUMAB N01, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Four-Pronged attack on tough colon cancer

Disease control Recruiting now

This study is testing a new combination of four drugs for people with advanced colon cancer that has spread and has a specific genetic change called BRAF V600E. The goal is to see if this four-drug approach can better control the cancer and help patients live longer. The trial is…

Matched conditions: IPILIMUMAB N01

Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control

Last updated Apr 15, 2026 16:16 UTC

IPILIMUMAB N01

Get alerted when new IPILIMUMAB N01 trials appear

Four-Pronged attack on tough colon cancer